App-Quantinova.ai

Bone turnover in pregnancy, measured by urinary C-terminal telopeptide of type I collagen (CTX), is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the MAVIDOS trial

Elizabeth M Curtis - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

cholecalciferol

The epidemiology of antiphospholipid syndrome in the UK, 1990-2016

Mia Rodziewicz - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Antiphospholipid syndrome

N/A

The usability of electronic patient-reported outcomes prior to rheumatology clinic attendance: could this be the future in managing demand on rheumatology services?

Melanie J Martin - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

N/A

Ankylosing spondylitis associated polymorphism of the IL7R controls expression surface and soluble IL7R-alpha during in inflammation

Hussein Al-Mossawi - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Ankylosing spondylitis

N/A

Recommendations for acquisition and considerations for interpretation of MRI of the spine and sacroiliac joints in the investigation of axial spondyloarthritis in the UK

Tim J P Bray - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

N/A

Is computed tomography defined sacroiliitis suggestive of axial spondyloarthritis reported in patients with inflammatory bowel disease who are imaged for non-musculoskeletal indications?

Chong Seng Edwin Lim - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Inflammatory bowel disease

N/A

Multimorbidity in patients with axial spondyloarthritis: a cluster analysis

Sizheng Zhao - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

N/A

Exploring NICE criteria for continuing biologic therapies in axial spondyloarthritis: what is a suboptimal response?

Fariz Yahya - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

N/A

The diagnostic performance of ultrasound Doppler in a fast-track pathway for giant cell arteritis

Jonathan Pinnell - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell arteritis

N/A

Implementing screening for hydroxychloroquine ocular toxicity: how big is the problem? Epidemiology of hydroxychloroquine prescriptions in the UK Clinical Practice Research Datalink

Fiona A Pearce - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Hydroxychloroquine

A prospective audit of a patient cohort prescribed hydroxychloroquine in order to estimate the burden of retinopathy screening and service requirements for drug education appointments

Brandon Yeo - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic retinopathy

Hydroxychloroquine

Gout in primary care: can we improve patient outcomes?

Georgina Blakey - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Gout

N/A

Changes in the management of systemic sclerosis-related digital ulcer disease between 2015-2017 across devolved nations of the United Kingdom: a multi-centre service evaluation project across South West England and Wales

Elizabeth Reilly - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

High rates of live varicella zoster vaccination amongst patients on biological therapy: an audit

Robbie K McLintock - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Shingles

Cyclophosphamide

Are we prescribing the correct dose of hydroxychloroquine?

Feon-Na Teh - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Hydroxychloroquine

Promoting self-management in patients with inflammatory arthritis: how do patients want education on self-management to be delivered?

Kristin Hindley - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Identifying patients who can be stepped down from biologic therapy for rheumatoid arthritis: a service evaluation and quality improvement project

Mariam Al-Attar - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Glucocorticoid

How well is methotrexate tolerated and adhered to in patients who are currently on maintenance therapy for rheumatic disorders? A survey undertaken in a large urban borough of London

Rizwan Rajak - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Methotrexate

Scottish Society for Rheumatology patient experience survey

Elizabeth Murphy - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Temporal artery biopsy: audit, scoring and reporting

Arundhati Chakrabarty - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Filters

45280 Abstracts